NCT01540461 2014-07-08
Determine the Pharmacokinetics and Safety of Brivanib in Chinese Subjects With Advanced Primary Liver Cancer (Hepatocellular Carcinoma: HCC)
Bristol-Myers Squibb
Phase 1 Completed
Clinical Trials
4 trialsNCT00437424 2011-05-04
A Study of Brivanib (BMS-582664) in Patients With Liver Cancer and Mild, Moderate or Severe Liver Dysfunction
Bristol-Myers Squibb
Phase 1 Completed
NCT00207051 2011-01-25
BMS-582664 in Combination With Erbitux in Patients With Advanced Gastrointestinal Malignancies
Bristol-Myers Squibb
Phase 1 Completed
NCT00300027 2010-03-02
Study of BMS-582664 in Combination With Either FOLFIRI or FOLFOX for Gastrointestinal (GI) Malignancies
Bristol-Myers Squibb
Phase 1 Terminated